Example: Heart Attack

Search clinical trials for: Micafungin

Total 63 results

NCT03421002

Completed

Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis

Conditions: Candidiasis, Systemic; Candida Meningitis
NCT02057289

Terminated

A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis

Conditions: Immunocompromised; Bone Marrow Transplant; Cancer
NCT02127788

Completed

Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology

Conditions: Antifungal Prophylaxis; Haemopathy
NCT01783379

Completed

Pharmacokinetics of Micafungin in Patients Intensive Care Unit

Conditions: Invasive Fungal Infection
NCT01417169

Unknown status

Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

Conditions: Neutropenia; Fungal Disease
NCT02440178

Completed

Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia

Conditions: Acute Leukemia
NCT02172768

Completed

Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease

Conditions: Acute Graft Versus Host Disease Grade II-IV; Allogeneic Stem Cell Transplant; Acute Myeloid Leucaemia; Myelo Dysplastic Syndrome
NCT03102658

Completed

Micafungin Pharmacokinetics in Obese Patients

Conditions: Morbid Obesity
NCT01974375

Unknown status

Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients

Conditions: Liver Transplant Recipient
NCT02651038

Completed

Pharmacokinetics of Micafungin During Continuous Venovenous Hemofiltration

Conditions: Candida Sepsis
NCT00818584

Completed

An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates

Conditions: Candida
NCT02646774

Terminated

Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis

Conditions: Invasive Aspergillosis
NCT00842504

Completed

Alternate Day Micafungin: A PK Study in Pediatric Patients

Conditions: Fungal Infection
NCT02678598

Completed

A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections

Conditions: Invasive Fungal Infections
NCT02646800

Terminated

Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

Conditions: Aspergillosis; Candidiasis
NCT00608335

Completed

Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Conditions: Oropharyngeal Candidiasis; Candidemia; Invasive Candidiasis; Esophageal Candidiasis
NCT00607763

Completed

Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Conditions: Invasive Candidiasis; Esophageal Candidiasis; Oropharyngeal Candidiasis; Candidemia
NCT01135589

Unknown status

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Conditions: Neutropenia; Hematopoietic Stem Cell Transplantation; Invasive Fungal Disease
NCT02164890

Completed

Pharmacokinetics of Micafungin in Patients of Intensive Care Units

Conditions: Invasive Candidiasis
NCT00809887

Terminated

Micafungin Lock Therapy

Conditions: Catheter-Related Fungal Infections
NCT00606268

Completed

A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant

Conditions: Fungal Infections
NCT01666769

Completed

Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation

Conditions: Invasive Candidiasis
NCT01200355

Completed

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Conditions: Acute Myelogenous Leukemia; Myelodysplastic Syndrome
NCT01344681

Completed

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

Conditions: Febrile Neutropenia; Hematological Diseases
NCT01888458

Completed

Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)

Conditions: Invasive Fungal Infection